PRAX

181.99

8.44% -16.77

Handel nachbörslich: 180.00 -1.99 -1.09%

Praxis Precision Medicines Inc (PRAX)

Überblick Nachrichten Preisverlauf Optionskette Financials Forum Prognose

Schlusskurs vom Vortag:

$198.76

Offen:

$180.49

24-Stunden-Volumen:

1.74M

Relative Volume:

2.17

Marktkapitalisierung:

$3.83B

Einnahmen:

$1.77M

Nettoeinkommen (Verlust:

$-123.74M

KGV:

-19.85

EPS:

-9.17

Netto-Cashflow:

$-95.21M

1W Leistung:

-2.12%

1M Leistung:

+234.66%

6M Leistung:

+352.26%

1J Leistung:

+166.34%

1-Tages-Spanne:

$167.03

$186.68

1-Wochen-Bereich:

$167.03

$206.71

52-Wochen-Spanne:

$26.70

$206.71

Praxis Precision Medicines Inc Stock (PRAX) Company Profile

Firmenname

Praxis Precision Medicines Inc

Sektor

Healthcare (1136)

Branche

Biotechnology (633)

Telefon

617-300-8460

Adresse

99 HIGH STREET, 30TH FLOOR, BOSTON

Mitarbeiter

Twitter

Nächster Verdiensttermin

2024-11-06

Neueste SEC-Einreichungen

PRAX's Discussions on Twitter

Vergleichen Sie PRAX mit anderen Aktien

Aktien	Preis	Marktkapitalisierung	Umsatz	Nettogewinn	Free Cashflow	ENV
PRAX Praxis Precision Medicines Inc	181.99	4.95B	1.77M	-123.74M	-95.21M	-9.17
VRTX Vertex Pharmaceuticals Inc	426.00	109.11B	11.39B	3.64B	3.50B	13.99
REGN Regeneron Pharmaceuticals Inc	642.25	68.50B	14.25B	4.58B	3.88B	41.77
ALNY Alnylam Pharmaceuticals Inc	434.07	60.25B	3.21B	43.57M	221.36M	0.2405
ARGX Argen X Se Adr	826.28	50.39B	3.06B	1.28B	447.35M	19.67
INSM Insmed Inc	186.23	40.44B	447.02M	-1.18B	-868.57M	-6.1812

Praxis Precision Medicines Inc Stock (PRAX) Upgrades & Downgrades

Datum	Aktion	Analytiker	Ratingänderung
2025-06-02	Fortgesetzt	Oppenheimer	Outperform
2025-05-07	Eingeleitet	Chardan Capital Markets	Buy
2025-03-03	Bestätigt	H.C. Wainwright	Buy
2025-02-11	Eingeleitet	Deutsche Bank	Buy
2024-08-05	Eingeleitet	Oppenheimer	Outperform
2024-06-24	Eingeleitet	Needham	Buy
2024-06-18	Eingeleitet	Guggenheim	Buy
2024-05-01	Eingeleitet	Robert W. Baird	Outperform
2023-09-19	Eingeleitet	Truist	Buy
2022-06-06	Herabstufung	Wedbush	Outperform → Neutral
2021-12-16	Eingeleitet	H.C. Wainwright	Buy
2021-08-26	Eingeleitet	BofA Securities	Buy
2021-04-26	Eingeleitet	William Blair	Outperform
2020-11-11	Eingeleitet	Wedbush	Outperform
2020-11-10	Eingeleitet	Cowen	Outperform
2020-11-10	Eingeleitet	Evercore ISI	Outperform
2020-11-10	Eingeleitet	Piper Sandler	Overweight

Alle ansehen

Praxis Precision Medicines Inc Aktie (PRAX) Neueste Nachrichten

11:34 AM

Oppenheimer Lifts Price Target for Praxis Medicines (PRAX), Keeps Outperform Rating - MSN

11:34 AM

09:37 AM

Is a relief rally coming for Praxis Precision Medicines Inc. holdersQuarterly Profit Review & Safe Investment Capital Preservation Plans - newser.com

09:37 AM

09:19 AM

How analysts rate Praxis Precision Medicines Inc. stock today2025 Fundamental Recap & Low Risk Growth Stock Ideas - newser.com

09:19 AM

09:12 AM

What institutional flow reveals about Praxis Precision Medicines Inc.2025 Fundamental Recap & Weekly High Momentum Picks - newser.com

09:12 AM

08:48 AM

Is Praxis Precision Medicines Inc. stock near bottom after decline2025 Buyback Activity & AI Enhanced Trading Alerts - newser.com

08:48 AM

08:07 AM

What valuation multiples suggest for Praxis Precision Medicines Inc. stockJuly 2025 Rallies & Free Safe Entry Trade Signal Reports - newser.com

08:07 AM

08:03 AM

How institutional buying supports Praxis Precision Medicines Inc. stockJuly 2025 Sector Moves & Verified Short-Term Plans - newser.com

08:03 AM

07:49 AM

Is Praxis Precision Medicines Inc. stock a contrarian buyJuly 2025 Reactions & Free Growth Oriented Trading Recommendations - newser.com

07:49 AM

07:18 AM

Published on: 2025-11-03 06:18:43 - newser.com

07:18 AM

07:06 AM

Can Praxis Precision Medicines Inc. stock deliver surprise earnings beatWeekly Risk Summary & High Yield Equity Trading Tips - newser.com

07:06 AM

06:20 AM

Applying big data sentiment scoring on Praxis Precision Medicines Inc.Bull Run & Reliable Volume Spike Trade Alerts - newser.com

06:20 AM

06:19 AM

Using Python tools to backtest Praxis Precision Medicines Inc. strategiesWeekly Volume Report & Weekly High Conviction Ideas - newser.com

06:19 AM

04:06 AM

Published on: 2025-11-03 03:06:20 - newser.com

04:06 AM

03:27 AM

Does Praxis Precision Medicines Inc. qualify in momentum factor screeningJuly 2025 Levels & Real-Time Chart Breakout Alerts - newser.com

03:27 AM

Nov 02, 2025

Published on: 2025-11-02 22:52:57 - newser.com

Nov 02, 2025

How Praxis Precision Medicines Inc. stock valuations compare to rivalsTrade Analysis Summary & Long-Term Capital Growth Strategies - newser.com

Nov 02, 2025

Nov 01, 2025

Praxis Precision Medicines prices $525M public offering - MSN

Nov 01, 2025

Published on: 2025-11-01 00:59:14 - newser.com

Nov 01, 2025

Oct 31, 2025

Praxis Precision Medicines (NASDAQ:PRAX) Reaches New 1-Year HighHere's What Happened - MarketBeat

Oct 31, 2025

Praxis Precision Medicines stock hits 52-week high at $206.36 By Investing.com - Investing.com Australia

Oct 31, 2025

Published on: 2025-10-31 03:19:21 - newser.com

Oct 31, 2025

Praxis Precision Medicines, Inc. (NASDAQ:PRAX) Given Consensus Rating of "Moderate Buy" by Brokerages - MarketBeat

Oct 31, 2025

Oct 30, 2025

Praxis Precision Medicines stock hits 52-week high at $206.36 - Investing.com

Oct 30, 2025

Praxis Precision Medicines (PRAX) Projected to Post Quarterly Earnings on Wednesday - MarketBeat

Oct 30, 2025

Oct 29, 2025

Published on: 2025-10-29 21:58:45 - newser.com

Oct 29, 2025

What’s Happening With Praxis Stock? - Trefis

Oct 29, 2025

Does Positive Phase 3 Data for Ulixacaltamide Transform the Outlook for Praxis Precision Medicines (PRAX)? - Sahm

Oct 29, 2025